Antibodies against HLA-DQ α-chain and their role in organ transplantation

Human Immunology

Volumn 70, Issue 6, 2009, Pages 410-412

  Barabanova, Yelena ^a   Ramon, Daniel S ^a   Tambur, Anat R ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

DQ alpha; HLA antibodies; Solid phase assays; Transplantation

Indexed keywords

HLA ANTIBODY; HLA DQ ANTIGEN; HLA DQ7 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CASE REPORT; FEMALE; FLOW CYTOMETRY; HETEROZYGOTE; HISTOCOMPATIBILITY; HLA MATCHING; HLA TYPING; HUMAN; IMMUNOREACTIVITY; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MALE; MULTIPLE PREGNANCY; PRIORITY JOURNAL; SIBLING;

FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HLA-DQ ANTIGENS; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; YOUNG ADULT;

EID: 67349187431     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.02.002     Document Type: Article

References (13)

1. Akalin E., and Watschinger B. Antibody-mediated rejection. Semin Nephrol 27 (2007) 393-407
2. Terasaki P., and Mizutani K. Antibody mediated rejection: Update 2006. Clin J Am Soc Nephrol 1 (2006) 400-403
3. Tosi R., Tanigaki N., Sorrentino R., Centis D., and Ferrara G.B. Serologically detectable polymorphism of the HLA-DC alpha-subunit. J Immunol 132 (1984) 277-282
4. Weinstien D., Brunt W.E., Cook D., McMahon J.T., Myles J., and Provita D. Ultra-late antibody mediated rejection 30 years after a living-related renal allograft. Am J Trans 5 (2005) 2576-2581
5. Campbell R.D., and Milner C.M. MHC genes in autoimmunity. Curr Opin Immunol 5 (1993) 887-893
6. Nepom G.T., and Erlich H. MHC class-II molecules and autoimmunity. Annu Rev Immunol 9 (1991) 493-525
7. Thorsby E., and Ronningen K.S. Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36 (1993) 371-377
8. Kwok W.W., Thurtle P., and Nepom G.T. A genetically controlled pairing anomaly between HLA-DQ alpha and HLA-DQ beta chains. J Immunol 143 (1989) 3598-3601
9. Sollid L.M. Molecular basis of celiac disease. Annu Rev Immunol 18 (2000) 53-81
10. Congia M., Frau F., Lampis R., Frau R., Mele R., Cucca F., et al. A high frequency of the A30, B18, DR3, DRw52, DQw2 extended haplotype in Sardinian celiac disease patients: Further evidence that disease susceptibility is conferred by DQ A1*0501, B1*0201. Tissue Antigens 39 (1992) 78-83
11. Tosi R., Vismara D., Tanigaki N., Ferrara G.B., Cicimarra F., Buffolano W., et al. Evidence that celiac disease is primarily associated with a DC locus allelic specificity. Clin Immunol Immunopathol 28 (1983) 395-404
12. Hall M.A., Lanchbury J.S., Lee J.S., Welsh K.I., and Ciclitira P.J. HLA-DQ2 second-domain polymorphisms may explain increased trans-associated risk in celiac disease and dermatitis herpetiformis. Hum Immunol 38 (1993) 284-292
13. van deWal Y., Kooy Y.M.C., Drijfhout J.W., Amons R., Papadopoulos G.K., and Koning F. Unique peptide binding characteristics of the disease-associated DQ(A1*0501, B1*0201) vs the non-disease-associated DQ(A1*0201, B1*0202) molecule. Immunogenetics 46 (1997) 484-492